Search company, investor...

Predict your next investment

Delian Capital company logo
Venture Capital
bjdeliancap.com

Investments

78

Portfolio Exits

4

About Delian Capital

Delian Capital is an investment management agency focused on the transformation and upgrading of China's traditional industries, in a mature or high-growth stage of investment opportunities for small and medium private enterprises. The firm is mainly concerned on areas including new materials, new energy, resource comprehensive utilization based environmental protection, high-end manufacturing, medical health, TMT, and other fields.

Headquarters Location

Suite 1907, Office Tower E1 Oriental Plaza, No.1East

Beijing, Beijing,

China

+86 10 8518 8998 825

Want to inform investors similar to Delian Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Delian Capital News

Chip Design Firm Luxic Secures Hundreds of Millions of Yuan in Financing

Sep 28, 2022

Pandaily Among them, the pre-A round was led by Source Code Capital and followed by Xinyang Venture Capital, Delian Capital and Legend Star, its existing shareholder. Round-A financing was led by China Fortune-Tech Capital, followed by Source Code Capital and SMIC. The funds raised this time will mainly be used for the company’s technology R&D, product development, mass production and product delivery, as well as for promoting the market promotion of high-speed optical communication products. Luxic was established in September 2020. The company’s founders come mostly from internationally renowned manufacturers and have many years of experience in R&D of optoelectronic chips. It currently has more than 30 employees, with research personnel accounting for more than 70%. In terms of market expansion, it has entered into the supply chain of major international factories with various products. In the field of optical communications, it has introduced several common electrical chips such as TIAs (transimpedance amplifiers), CDRs (clock and data recovery circuits) and drivers. For the consumer sector, it has launched HDMI (high-definition multimedia interface) chips. Luxic’s chip solutions can cover full-range (SR-ZR+) application scenarios with transmission rates ranging from 25G to 800G. Core mass production products such as single wave 100G chips have been introduced into major module factories. The company is developing a digital single wave 200G chip, which can be used on digital 800G and 1.6T optical modules. The corresponding products are expected to be available by the end of the year. In addition, the company has begun to explore relevant technologies for lidar, focusing on the solutions market of conversion chips for vehicle-mounted applications. With the development of 5G, AIoT, cloud computing and other applications, data transmission is moving towards higher speeds. With the construction of many high-speed data centers, the field of optical modules required for data center photoelectric conversion is growing rapidly.

Delian Capital Investments

78 Investments

Delian Capital has made 78 investments. Their latest investment was in Hunan Tree Industrial Manufacturing as part of their Series A on August 8, 2023.

CBI Logo

Delian Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/2/2023

Series A

Hunan Tree Industrial Manufacturing

$13.93M

Yes

2

6/12/2023

Series A

Yaoshi Medical Technology

Yes

3

4/3/2023

Series A - II

D2M Biotherapeutics

No

1

3/30/2023

Series A

Subscribe to see more

Subscribe to see more

10

12/26/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/2/2023

6/12/2023

4/3/2023

3/30/2023

12/26/2022

Round

Series A

Series A

Series A - II

Series A

Series A

Company

Hunan Tree Industrial Manufacturing

Yaoshi Medical Technology

D2M Biotherapeutics

Subscribe to see more

Subscribe to see more

Amount

$13.93M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

1

10

10

Delian Capital Portfolio Exits

4 Portfolio Exits

Delian Capital has 4 portfolio exits. Their latest portfolio exit was MicuRx Pharmaceuticals on August 05, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/5/2022

IPO

$99M

Public

1

12/21/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/10/2019

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/9/2018

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/5/2022

12/21/2021

12/10/2019

5/9/2018

Exit

IPO

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Delian Capital Team

1 Team Member

Delian Capital has 1 team member, including former Senior Vice President, Guobao Zhao.

Name

Work History

Title

Status

Guobao Zhao

Senior Vice President

Former

Name

Guobao Zhao

Work History

Title

Senior Vice President

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.